Neuropediatrics 2011; 42(06): 254-256
DOI: 10.1055/s-0031-1295477
Short Communication
© Georg Thieme Verlag KG Stuttgart · New York

Cerebrospinal Fluid IL-6, TNF-α and MCP-1 in Children with Acute Lymphoblastic Leukaemia during Chemotherapy

P. T. Protas
1  Department of Clinical Pharmacology, Medical University of Bialystok, Bialystok, Poland
,
A. Holownia
1  Department of Clinical Pharmacology, Medical University of Bialystok, Bialystok, Poland
,
K. Muszynska-Roslan
2  Department of Paediatric Oncology, Medical University of Bialystok, Bialystok, Poland
,
P. Wielgat
1  Department of Clinical Pharmacology, Medical University of Bialystok, Bialystok, Poland
,
M. Krawczuk-Rybak
2  Department of Paediatric Oncology, Medical University of Bialystok, Bialystok, Poland
,
J. J. Braszko
1  Department of Clinical Pharmacology, Medical University of Bialystok, Bialystok, Poland
› Author Affiliations
Further Information

Publication History

received 28 December 2011

accepted 03 November 2011

Publication Date:
05 December 2011 (eFirst)

Abstract

The aim of the study was to investigate the levels of cerebrospinal fluid (CSF) cytokines during chemotherapy of acute lymphoblastic leukaemia (ALL). Examination of 12 ALL child (6 boys and 6 girls) patients evidenced significant increases in interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) after induction treatment and significant increases in IL-6, tumour necrosis factor-α (TNF-α) and MCP-1 levels during the consolidation phase, as compared to their values at the time of diagnosis. There were no significant differences in CSF IL-6, TNF-α and MCP-1 concentrations after therapy. Our data suggest that standard ALL treatment may cause a subclinical inflammation and neurotoxicity.